FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular to a method for pre-payment genetic testing of a pathogenic variant NC_000015.9:g.48725062C>G (NM_000138.5:c.6739+1G>C) in the FBN1 gene, associated with Marfan syndrome. Said method involves detecting the inheritance of said pathogenic variant and includes a dual detection system – direct and indirect, where direct detection is carried out using primers for amplification, characterized by sequences SEQ ID NO: 36-41, and indirect detection is carried out using primers for analysis of inheritance of molecular genetic markers of STR type, linked to a pathogenic variant, selected from SEQ ID NO: 1-35.
EFFECT: present invention provides a test system for diagnosing a pathogenic variant NC_000015.9:g_48725062C>G (NM_000138.5:c_6739+1G>C) in the FBN1 gene with dual detection system – direct and indirect.
1 cl, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF HUNTINGTON'S DISEASE | 2024 |
|
RU2840728C1 |
PREIMPLANTATION METHOD OF MARTINE-BELL SYNDROME GENETIC TESTING | 2022 |
|
RU2796834C1 |
METHOD FOR PREIMPLANTATION GENETIC TESTING OF STARGARDT DISEASE | 2023 |
|
RU2831940C1 |
PREIMPLANTATION GENETIC TESTING METHOD FOR ACHONDROPLASIA | 2022 |
|
RU2795482C1 |
METHOD FOR PREIMPLANTATION GENETIC TESTING OF SMITH-LEMLI-OPITZ SYNDROME | 2023 |
|
RU2816650C1 |
METHOD OF PREIMPLANTATION GENETIC TESTING OF HEREDITARY ZONULAR CATARACT | 2022 |
|
RU2799541C1 |
PREIMPLANTATION GENETIC TESTING METHOD FOR ALPORT SYNDROME | 2022 |
|
RU2795481C1 |
METHOD OF PREIMPLANTATION GENETIC TESTING OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY | 2023 |
|
RU2808833C1 |
METHOD OF PREIMPLANTATION GENETIC TESTING FOR SPONDYLOEPIPHYSEAL DYSPLASIA | 2022 |
|
RU2803650C1 |
METHOD FOR PREIMPLANTATION GENETIC TESTING OF TYPE 4 OSTEOPETROSIS | 2022 |
|
RU2795483C1 |
Authors
Dates
2025-03-26—Published
2023-11-24—Filed